Prescription drug · ANDA
Temsirolimus NDC 16729-223
Kit · Accord Healthcare Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 16729-223-61 | 1672902236116729022361 | 1 KIT in 1 KIT (16729-223-61) * 1 mL in 1 VIAL, SINGLE-DOSE (16729-221-30) * 1.8 mL in 1 VIAL, SINGLE-DOSE (16729-222-30)Marketed from Aug 13, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Temsirolimus
- Generic name (nonproprietary)
- temsirolimus
- Dosage form
- Kit
- Labeler
- Accord Healthcare Inc.NDC labeler code 16729
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203153
- Marketing start
- Listing expires
- Identifiers
- Product ID 16729-223_116814b6-e438-8a45-e063-6394a90a9fadSPL ID 116814b6-e438-8a45-e063-6394a90a9fadSPL set ID ae8d2354-7ddb-41b8-9d55-77c84782b18fRxCUI 722289UPC 0316729222303
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N416729022361followed by a unit qualifier and the quantityPackage 16729-0223-61. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Temsirolimus injection is indicated for the treatment of advanced renal cell carcinoma. Temsirolimus injection is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 16729-223
- What is NDC 16729-223?
- 16729-223 is the product NDC for Temsirolimus kit, listed with the FDA by Accord Healthcare Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Temsirolimus.
- Who is the labeler?
- Accord Healthcare Inc., NDC labeler code 16729. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Temsirolimus?
- 3 other product NDCs are listed under this name. See all Temsirolimus NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Temsirolimus products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Temsirolimus | — | KitIntravenous | Fresenius Kabi USA, LLC | 65219-200 | 65219-0200-05 |
| Temsirolimustemsirolimus injection | — | Kit | Almaject, Inc. | 72611-785 | 72611-0785-02 |
| Temsirolimustemsirolimus injection | — | Kit | Gland Pharma Limited | 68083-202 | 68083-0202-01 |